Biotechnology

Codexis

$25.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.39 (+1.53%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Codexis and other stocks, options, and ETFs commission-free!

About CDXS

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA. The listed name for CDXS is Codexis, Inc. Common Stock.

CEO
John J. Nicols
Employees
161
Headquarters
Redwood City, California
Founded
2002
Market Cap
1.65B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
638.47K
High Today
$26.24
Low Today
$25.14
Open Price
$25.41
Volume
824.57K
52 Week High
$27.10
52 Week Low
$8.43

Collections

CDXS Earnings

-$0.19
-$0.11
-$0.04
$0.04
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours

You May Also Like

ALUS+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure